摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-bromo-1,1-dimethoxy-nonane | 743460-22-2

中文名称
——
中文别名
——
英文名称
9-bromo-1,1-dimethoxy-nonane
英文别名
9-Bromo-1,1-dimethoxynonane
9-bromo-1,1-dimethoxy-nonane化学式
CAS
743460-22-2
化学式
C11H23BrO2
mdl
——
分子量
267.206
InChiKey
ZJOXEVPNSRFIDV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    82-84 °C(Press: 0.2 Torr)
  • 密度:
    1.130±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    14
  • 可旋转键数:
    10
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:d959c815b870ffb2627bebf965a33136
查看

反应信息

  • 作为反应物:
    描述:
    9-bromo-1,1-dimethoxy-nonane[1,1'-联苯]-2-基氨基甲酸4-哌啶基酯三乙胺 作用下, 以 乙腈 为溶剂, 反应 6.0h, 以84%的产率得到biphenyl-2-ylcarbamic Acid 1-(9,9-Dimethoxynonyl)piperidin-4-yl Ester
    参考文献:
    名称:
    Biphenyl derivatives
    摘要:
    这项发明提供了式I中的联苯衍生物:其中R1、R2、R3、R4、R5、R6、R7、W、a、b和c如规范中定义,或其药学上可接受的盐、溶剂或立体异构体。本发明的联苯衍生物具有β2肾上腺素受体激动剂和肌力抑制剂活性,因此,这种联苯衍生物可用于治疗肺部疾病,如慢性阻塞性肺疾病和哮喘。
    公开号:
    US20040167167A1
  • 作为产物:
    描述:
    9-bromononanal原甲酸三甲酯盐酸 作用下, 以 1,4-二氧六环甲醇乙酸乙酯 为溶剂, 反应 3.0h, 以97%的产率得到9-bromo-1,1-dimethoxy-nonane
    参考文献:
    名称:
    Crystalline form of a biphenyl compound
    摘要:
    该发明提供了双苯基氨基甲酸1-{9-[(R)-2-羟基-2-(8-羟基-2-氧代-1,2-二氢喹啉-5-基)乙基]壬基}哌嗪-4-基酯的萘-1,5-二磺酸盐晶体或其溶剂化物。该发明还提供了包含此种盐或使用此种盐制备的药物组合物;制备此种盐的过程和中间体;以及使用此种盐治疗肺部疾病的方法。
    公开号:
    US20050182092A1
点击查看最新优质反应信息

文献信息

  • Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
    申请人:Mammen Mathai
    公开号:US20050113417A1
    公开(公告)日:2005-05-26
    The invention is directed to compounds of formula I: wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7a , R 7b , W, G 1 , G 2 , a, b, c, d and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
    这项发明涉及到以下式I的化合物:其中R1、R2、R3、R4、R5、R6、R7a、R7b、W、G1、G2、a、b、c、d和m如规范中所定义,或其药学上可接受的盐、溶剂或立体异构体。该发明还涉及包含这些化合物的药物组合物;使用这些化合物的方法;以及制备这些化合物的过程和中间体。
  • DIALKOXYALKADIENYNE COMPOUND AND A PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING A DIENYNAL COMPOUND
    申请人:Shin-Etsu Chemical Co., Ltd.
    公开号:US20210061744A1
    公开(公告)日:2021-03-04
    A process for preparing a dienynal compound of the following general formula (2): CH 2 ═CHC≡CCH═CH(CH 2 ) n CHO (2), wherein n represents an integer of 0 to 11, the process comprising a step of hydrolyzing a dialkoxyalkadienyne compound of the following general formula (1): CH 2 ═CHC≡CCH═CH(CH 2 ) n CH(OR 1 )(OR 2 ) (1) wherein R 1 and R 2 represent, independently of each other, a monovalent hydrocarbon group having 1 to 15 carbon atoms, preferably 1 to 8, mere preferably 1 to 4, or R 1 and R 2 may be bonded to each other to form a divalent hydrocarbon group, R 1 -R 2 , having from 2 to 10 carbon atoms, and n represents an integer of 0 to 11, to obtain the dienynal compound (2).
    制备下列一般式(2)的二烯醛化合物的过程:CH2═CHC≡CCH═CH(CH2)nCHO(2),其中n代表0到11的整数,该过程包括水解以下一般式(1)的二烯炔烯化合物的步骤:CH2═CHC≡CCH═CH(CH2)nCH(OR1)(OR2)(1),其中R1和R2分别表示独立的具有1至15个碳原子的一价碳氢基团,优选1至8,更优选1至4,或者R1和R2可以结合在一起形成具有2至10个碳原子的二价碳氢基团R1-R2,n代表0到11的整数,以获得二烯醛化合物(2)。
  • PROCESS FOR PREPARING 4-PENTEN-2-YNAL
    申请人:Shin-Etsu Chemical Co., Ltd.
    公开号:US20210061745A1
    公开(公告)日:2021-03-04
    A process for preparing 4-penten-2-ynal of the following formula (2): CH 2 ═CHC≡CCHO  (2) the process comprising a step of hydrolyzing a 5,5-dialkoxy-1-penten-3-yne compound of the following general formula (1): CH 2 ═CHC≡CCH(OR 1 )(OR 2 )  (1) wherein R 1 and R 2 represent, independently of each other, a monovalent hydrocarbon group having 1 to 15 carbon atoms, preferably 1 to 8, more preferably 1 to 4, or R 1 and R 2 may be bonded to each other to form a divalent hydrocarbon group, R 1 -R 2 , having from 2 to 10 carbon atoms, to obtain 4-penten-2-ynal (2).
    制备4-戊烯-2-炔醛的方法如下(2):CH2═CHC≡CCHO  (2),该方法包括以下步骤:水解以下通式(1)的5,5-二烷氧基-1-戊烯-3-炔化合物:CH2═CHC≡CCH(OR1)(OR2)  (1),其中R1和R2分别表示具有1至15个碳原子的1价烃基,优选1至8个碳原子,更优选1至4个碳原子,或R1和R2可以结合在一起形成具有2至10个碳原子的2价烃基R1-R2,以获得4-戊烯-2-炔醛(2)。
  • Library of biphenyl derivatives
    申请人:——
    公开号:US20040209915A1
    公开(公告)日:2004-10-21
    This invention provides a library of biphenyl derivatives of formula I: 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , W, a, b and c are as defined in the specification, or a salt or stereoisomer thereof. The library is useful for identifying compounds having both &bgr; 2 adrenergic receptor agonist and muscarinic receptor antagonist activity. Accordingly, this invention also provides methods of evaluating or screening a library of biphenyl derivatives to identifying compounds having such bifunctional activity.
    本发明提供了一种公式I的联苯衍生物库:1其中R1、R2、R3、R4、R5、R6、R7、W、a、b和c如规范中所定义,或其盐或立体异构体。该库对于鉴定具有β2肾上腺素能受体激动剂和肌动蛋白受体拮抗剂活性的化合物非常有用。因此,本发明还提供了评估或筛选联苯衍生物库以鉴定具有这种双重功能活性的化合物的方法。
  • Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
    申请人:——
    公开号:US20040209860A1
    公开(公告)日:2004-10-21
    This invention provides biphenyl derivatives containing (i) a (biphenyl-2-yl)oxycarbonylamino- or (biphenyl-2-yl)aminocarbonylamino-substituted (2-7C)azacycloalkyl or (5-10C)azabicycloalkyl group; (ii) a substituted 2-(4-hydroxyphenyl)-2-hydroxyethylamino group; and a divalent hydrocarbon group, where each group is further defined and optionally substituted as described in the specification. The biphenyl derivatives of the invention possess both &bgr; 2 adrenergic receptor agonist and muscarinic receptor antagonist activity and therefore, such biphenyl derivatives are useful for treating pulmonary disorders, such as chronic obstructive pulmonary disease and asthma.
    该发明提供了含有以下结构的联苯衍生物:(i)一个(biphenyl-2-yl)oxycarbonylamino-或(biphenyl-2-yl)aminocarbonylamino取代的(2-7C)氮杂环烷基或(5-10C)氮杂双环烷基;(ii)一个取代的2-(4-羟基苯基)-2-羟乙基氨基基团;以及一个二价碳氢基团,其中每个基团进一步在说明书中描述并可选地取代。该发明的联苯衍生物具有β2肾上腺素受体激动剂和毒蕈碱受体拮抗剂活性,因此,这种联苯衍生物对于治疗肺部疾病,如慢性阻塞性肺疾病和哮喘,是有用的。
查看更多